Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.

Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG.

PLoS One. 2015 Dec 3;10(12):e0143433. doi: 10.1371/journal.pone.0143433. eCollection 2015.

2.

Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.

Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG.

JAMA Intern Med. 2016 Jan 1;176(1):65-73. doi: 10.1001/jamainternmed.2015.6011.

PMID:
26595724
3.

Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation.

Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT.

Neurosurg Focus. 2014 Nov;37(5):E8. doi: 10.3171/2014.8.FOCUS14435.

PMID:
26218621
4.

Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening.

Curl PK, Kahn JG, Ordovas KG, Elicker BM, Naeger DM.

AJR Am J Roentgenol. 2015 Aug;205(2):344-7. doi: 10.2214/AJR.14.14038. Review.

PMID:
26204285
5.

Research ethics and health care reform.

Kahn JG, Hofmann P.

Science. 2015 Jun 19;348(6241):1325-6. doi: 10.1126/science.348.6241.1325-b. No abstract available.

PMID:
26089503
6.

Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya?

Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL.

Glob Health Action. 2015 Jun 10;8:27695. doi: 10.3402/gha.v8.27695. eCollection 2015.

7.

Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma.

Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG.

PLoS One. 2015 Apr 20;10(4):e0126988. doi: 10.1371/journal.pone.0126988. eCollection 2015. No abstract available.

8.

Thresholds for the cost-effectiveness of interventions: alternative approaches.

Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S.

Bull World Health Organ. 2015 Feb 1;93(2):118-24. doi: 10.2471/BLT.14.138206. Epub 2014 Dec 15.

9.

Cost-effectiveness research in neurosurgery.

Zygourakis CC, Kahn JG.

Neurosurg Clin N Am. 2015 Apr;26(2):189-96, viii. doi: 10.1016/j.nec.2014.11.008. Epub 2014 Nov 6. Review.

PMID:
25771274
10.

Saving lives and saving money: hospital-based violence intervention is cost-effective.

Juillard C, Smith R, Anaya N, Garcia A, Kahn JG, Dicker RA.

J Trauma Acute Care Surg. 2015 Feb;78(2):252-7; discussion 257-8. doi: 10.1097/TA.0000000000000527.

PMID:
25757108
11.

Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research.

Mirzazadeh A, Malekinejad M, Kahn JG.

J Clin Epidemiol. 2015 Mar;68(3):317-23. doi: 10.1016/j.jclinepi.2014.11.013. Epub 2014 Dec 18.

PMID:
25726522
12.

Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.

Chen IT, Aung T, Thant HN, Sudhinaraset M, Kahn JG.

Malar J. 2015 Feb 5;14:55. doi: 10.1186/s12936-015-0569-7.

13.

Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe.

Downing J, El Ayadi A, Miller S, Butrick E, Mkumba G, Magwali T, Kaseba-Sata C, Kahn JG.

BMC Health Serv Res. 2015 Jan 28;15:37. doi: 10.1186/s12913-015-0694-6.

14.

Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence.

Jiwani A, Himmelstein D, Woolhandler S, Kahn JG.

BMC Health Serv Res. 2014 Nov 13;14:556. doi: 10.1186/s12913-014-0556-7.

15.

Avahan and the cost-effectiveness of "prevention as prevention".

Marseille E, Kahn JG.

Lancet Glob Health. 2014 Sep;2(9):e493-4. doi: 10.1016/S2214-109X(14)70295-5. Epub 2014 Aug 27. No abstract available.

16.

Global cost-effectiveness of GDM screening and management: current knowledge and future needs.

Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N.

Best Pract Res Clin Obstet Gynaecol. 2015 Feb;29(2):206-24. doi: 10.1016/j.bpobgyn.2014.06.009. Epub 2014 Aug 21. Review.

PMID:
25225056
17.

Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma.

Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG.

PLoS One. 2014 Sep 8;9(9):e107255. doi: 10.1371/journal.pone.0107255. eCollection 2014. Erratum in: PLoS One. 2015;10(4):e0126988.

18.

Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.

Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG.

BMJ Open. 2014 Jun 26;4(6):e003987. doi: 10.1136/bmjopen-2013-003987.

19.

Modeling scenarios for the end of AIDS.

Lima VD, Thirumurthy H, Kahn JG, Saavedra J, Cárceres CF, Whiteside A.

Clin Infect Dis. 2014 Jul;59 Suppl 1:S16-20. doi: 10.1093/cid/ciu339.

20.

Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach.

Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson J.

BMJ Open. 2014 Mar 19;4(3):e004308. doi: 10.1136/bmjopen-2013-004308.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk